FDA Inspection 1237349 — Daicel Chiral Technologies (India) Private Limited
The FDA completed an inspection of Daicel Chiral Technologies (India) Private Limited on November 3, 2023 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 3, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Bioanalytical BA/BE